Biologics CDMO — Built for Difficult Programs

CHO/HEK platforms. DoE-driven process development. IND-ready documentation. Non‑GMP scale-up with clear tech transfer.

CHO/HEK stable lines with multi‑g/L productivity. Monoclonality and stability confirmed.

Design‑of‑Experiments (DoE) for upstream/downstream with defined CPP/CQA ranges.

Identity, purity, glycan/charge, potency, safety — methods ready for transfer.

Engineering runs and tox supply to de‑risk GMP; complete CMC documentation.